|
Hotstockpress.com: RedHotOTC.com --Study Confirms SinoFresh (OTCBB:
SFSH) Product Kills MRSA Super-Bug
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:22082008
SinoFresh Next Level "Super-Bug" MRSA Treatment Overview
Study Confirms SinoFresh Product Kills MRSA "Super-Bug"
VENICE, FL--Aug 22, 2008 -- SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB
- News) Following are the advances towards effectively managing MRSA
"Super-Bug", utilizing already available products from SinoFresh
Healthcare, Inc.
Announcements:
--SinoFresh Elaborates on New Study Designed to Demonstrate Nasal Spray
Formulation Efficacy in Decolonization of MRSA "Super Bug" in the Nasal
Passage
-- On the heels of the recent announcement stating a commitment to
develop a product to attack MRSA -- the so-called "super bug,"
SinoFresh HealthCare, Inc. (OTCBB: SFSH) announced today the
continuation of a series of development activities to implement that
commitment. This is a study, which will be in the lab phase by the end
of July 2008, and according to Dr. John Todhunter, an outside
consultant to SinoFresh, "is expected to give robust proof of concept
for the nasal formulation designed to kill MRSA hiding in the nose."
--SinoFresh Announces "Next Step" in Program to Attack "Super-Bug" MRSA
-- SinoFresh HealthCare, Inc. (OTCBB: SFSH)the makers of SinoFresh
Nasal Spray, announced today the next step in a research and
development program expected to lead to a nasal spray product for
attacking MRSA -- the so-called "super bug" -- reservoirs in the nasal
passage. These nasal reservoirs are believed by public health experts
to be a significant source of MRSA infections. "This continuation of an
earlier study is a concrete expression of SinoFresh's commitment to
exploring ways to protect and promote nasal and upper respiratory
health and hygiene," according to Charles Fust, CEO of SinoFresh. In
July 2005, SinoFresh announced it had achieved positive results in an
in vitro study conducted at the Public Health Research Institute under
the direction of Dr. Barry Kreiswirth who is the director of the
institute's Tuberculosis Center and Hospital Infections Program.
--SinoFresh(R) Nasal Spray Kills MRSA "Super-Bug" in Live Noses
--SinoFresh(R) Passes First Key Test for Potential to Control "Super-
Bug" MRSA
According to William Wilferth, VP for Research and Development at
SinoFresh, "These results have exceeded our expectations. The positive
results of this in vivo study gives us the solid scientific platform we
have needed in order to advance our efforts to fight MRSA to the next
level."
SinoFresh nasal spray attacks MRSA in the nasal passages by destroying
the "super-bug's" cell walls and membranes by physical means rather
than by an antibiotic mechanism involving attack on the metabolism of
the microbes as occurs with the use of antibiotics. "Since bacteria can
in effect change their metabolism to be resistant to antibiotics, but
can't very well change the laws of physics the chances for development
of resistance to SinoFresh Nasal Spray's mode of killing them is much
lower," said Dr. Todhunter.
About SinoFresh HealthCare, Inc.
SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News) is a developer and
marketer of innovative upper respiratory system therapies. The company
is researching broad-spectrum antiseptic approaches to reducing viral,
bacterial and fungal organisms that are suspected to cause pathogenesis
of the mouth, nose and throat. The company's lead product, SinoFresh
Nasal and Sinus Care, is a hygienic cleansing spray that kills germs
and removes other nasal-sinus irritants. The company is also
researching how antiseptic cleansing may alleviate chronic sinus
distress, a condition that may affect 37 million Americans annually.
SinoFresh products are available in major retail outlets nationwide.
Source: SinoFresh Healthcare, Inc.
CONTACT: William Wilferth, R. Ph. M.S.VP Research & Development,
SinoFresh HealthCare Inc
Tel: +1 941 488 9090
WWW: http://www.sinofresh.com
Investor / Public Relations, Media Contact, Mica Capital Partners, LLC
Tel: +1 888 522 5613
e-mail: info@redhototc.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To MobilityTechzone Homepage's Homepage ]
|